Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.030
+0.010 (0.98%)
Feb 3, 2026, 4:00 PM EST - Market closed

Evogene Revenue

Evogene had revenue of $312.00K in the quarter ending September 30, 2025, a decrease of -82.63%. This brings the company's revenue in the last twelve months to $5.25M, down -26.75% year-over-year. In the year 2024, Evogene had annual revenue of $8.51M with 50.90% growth.

Revenue (ttm)
$5.25M
Revenue Growth
-26.75%
P/S Ratio
1.10
Revenue / Employee
$68,513
Employees
117
Market Cap
8.79M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20248.51M2.87M50.90%
Dec 31, 20235.64M3.97M236.72%
Dec 31, 20221.68M745.00K80.11%
Dec 31, 2021930.00K-110.00K-10.58%
Dec 31, 20201.04M287.00K38.11%
Dec 31, 2019753.00K-994.00K-56.90%
Dec 31, 20181.75M-1.63M-48.33%
Dec 31, 20173.38M-3.16M-48.30%
Dec 31, 20166.54M-4.59M-41.23%
Dec 31, 201511.13M-3.38M-23.31%
Dec 31, 201414.51M-3.07M-17.46%
Dec 31, 201317.58M509.00K2.98%
Dec 31, 201217.07M2.17M14.57%
Dec 31, 201114.90M2.34M18.61%
Dec 31, 201012.56M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition